Table 3

Intent-to-treat evaluation of exposure to antimicrobials in study patients distributed in two arms: empirical treatment and targeted treatment

Exposure to antimicrobialsEmpirical treatment (n=89)Targeted treatment (n=88)
Broad-spectrum antimicrobials
 Ceftriaxone, IV32.838.8
 Levofloxacin, IV16.212.7
 Levofloxacin, oral23.819.4
 Amoxicillin–clavulanate, IV3.93.0
 Amoxicillin–clavulanate, oral72.749.4
 Cefditoren, oral33.931.1
Narrow-spectrum antimicrobials
 Azithromycin, IV30.135.1
 Azithromycin, oral18.213.0
 Amoxicillin, oral050.1
  • Data are presented as defined daily doses per 100 patient days.

  • IV, intravenous.